Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Localized paclitaxel delivery.

A B Dhanikula1, R Panchagnula

  • 1Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Sector 67, S.A.S Nagar, Punjab 160 062, India.

International Journal of Pharmaceutics
|June 11, 1999
PubMed
Summary

Localized paclitaxel delivery enhances cancer treatment by increasing drug concentration and exposure time. This approach shows promise for managing solid tumors and reducing systemic side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dermal drug delivery: Revisited.

Drug discoveries & therapeutics·2012
Same author

Solid-state characterization of nevirapine.

Indian journal of pharmaceutical sciences·2011
Same author

A decision tree for rapid quality assurance and control of rifampicin-containing oral dosage forms for global distribution for tuberculosis treatment.

Indian journal of pharmaceutical sciences·2010
Same author

Alteration of skin hydration and its barrier function by vehicle and permeation enhancers: a study using TGA, FTIR, TEWL and drug permeation as markers.

Methods and findings in experimental and clinical pharmacology·2008
Same author

Thermoreversible liposomal poloxamer gel for the delivery of paclitaxel: dose proportionality and hematological toxicity studies.

Die Pharmazie·2008
Same author

Studies of the skin permeation of lipophilic drugs: paclitaxel.

Die Pharmazie·2007

Area of Science:

  • Oncology
  • Pharmacology
  • Biomedical Engineering

Background:

  • Optimizing existing antineoplastic agents is crucial for cancer management.
  • Paclitaxel offers significant pharmacokinetic and therapeutic benefits through localized delivery.
  • The antiangiogenic activity of paclitaxel is a key area of research.

Purpose of the Study:

  • To review the antiangiogenic activity of paclitaxel.
  • To explore the synergistic potential of angiogenesis inhibitors with cytotoxic agents.
  • To highlight the advantages of localized paclitaxel delivery for cancer treatment.

Main Methods:

  • Review of preclinical studies on paclitaxel's antiangiogenic effects.
  • Analysis of evidence supporting the combination of angiogenesis inhibitors and cytotoxic agents.
  • Examination of drug delivery systems for localized paclitaxel administration.

Main Results:

  • Paclitaxel demonstrates antiangiogenic activity.
  • Increased drug concentration and duration of exposure enhance paclitaxel's effects on tumor cells.
  • Localized delivery systems like microspheres, pastes, and implants show promise.

Conclusions:

  • Localized paclitaxel delivery exploits multiple pharmacological effects for treating refractory and metastatic cancers.
  • Drug delivery systems can increase tumor burden while alleviating systemic drug burden.
  • Further development of localized delivery systems holds promise for solid tumor treatment.

Related Experiment Videos